Selected research
Market Structure
Global Computer-assisted Drug Design Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Computer-assisted Drug Design Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Computer-assisted Drug Design Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Computer-assisted Drug Design Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Computer-assisted Drug Design Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Computer-assisted Drug Design Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Computer-assisted Drug Design Platform include Entelos, Crown Bioscience, Chemical Computing Group, Nimbus Therapeutics, Schrodinger, Dassault Systemes, Genedata, Biognos and Leadscope, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Computer-assisted Drug Design Platform market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Computer-assisted Drug Design Platform and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Computer-assisted Drug Design Platform revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Computer-assisted Drug Design Platform market size, projected growth trends, production technologies, key applications, and end-use industries.
Computer-assisted Drug Design Platform Segment by Company
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Certara LP
Prosarix
Simulations Plus
Strand Life Sciences
Computer-assisted Drug Design Platform Segment by Type
Cloud-based
On-premise
Computer-assisted Drug Design Platform Segment by Application
Drug Discovery and Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis of Drug Targets
Computer-assisted Drug Design Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computer-assisted Drug Design Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Computer-assisted Drug Design Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computer-assisted Drug Design Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Computer-assisted Drug Design Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Computer-assisted Drug Design Platform industry.
Chapter 3: Detailed analysis of Computer-assisted Drug Design Platform companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Computer-assisted Drug Design Platformrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-premise
Applications
- Drug Discovery and Development
- Computational Physiological Medicine
- Disease Modeling
- Medical Imaging
- Predictive Analysis of Drug Targets
Companies covered
- Entelos
- Crown Bioscience
- Chemical Computing Group
- Nimbus Therapeutics
- Schrodinger
- Dassault Systemes
- Genedata
- Biognos
- Leadscope
- Rhenovia Pharma Limited
- Compugen
- Certara LP
- Prosarix
- Simulations Plus
- Strand Life Sciences
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Computer-assisted Drug Design Platform Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Cloud-based
- 1.2.3 On-premise
- 1.3 Market Analysis by Application
- 1.3.1 Global Computer-assisted Drug Design Platform Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Drug Discovery and Development
- 1.3.3 Computational Physiological Medicine
- 1.3.4 Disease Modeling
- 1.3.5 Medical Imaging
- 1.3.6 Predictive Analysis of Drug Targets
- 1.4 Global Market Growth Prospects
- 1.5 Global Computer-assisted Drug Design Platform Growth Trends by Region
- 1.5.1 Global Computer-assisted Drug Design Platform Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Computer-assisted Drug Design Platform Market Size by Region (2021-2026)
- 1.5.3 Computer-assisted Drug Design Platform Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Computer-assisted Drug Design Platform Market Dynamics
- 2.1 Computer-assisted Drug Design Platform Industry Trends
- 2.2 Computer-assisted Drug Design Platform Industry Drivers
- 2.3 Computer-assisted Drug Design Platform Industry Opportunities and Challenges
- 2.4 Computer-assisted Drug Design Platform Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Computer-assisted Drug Design Platform Revenue by Company (2021-2026)
- 3.2 Global Computer-assisted Drug Design Platform Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Computer-assisted Drug Design Platform Key Company Head office and Area Served
- 3.4 Global Computer-assisted Drug Design Platform Company, Product Type & Application
- 3.5 Global Computer-assisted Drug Design Platform Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Computer-assisted Drug Design Platform Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Computer-assisted Drug Design Platform Players Market Share by Revenue in 2025
- 3.6.3 2025 Computer-assisted Drug Design Platform Tier 1, Tier 2, and Tier 3
4 Computer-assisted Drug Design Platform Market by Type
- 4.1 Global Computer-assisted Drug Design Platform Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Computer-assisted Drug Design Platform Market Size by Type (2021-2032)
- 4.3 Global Computer-assisted Drug Design Platform Market Size Share by Type (2021-2032)
5 Computer-assisted Drug Design Platform Market by Application
- 5.1 Global Computer-assisted Drug Design Platform Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Computer-assisted Drug Design Platform Market Size by Application (2021-2032)
- 5.3 Global Computer-assisted Drug Design Platform Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Entelos
- 6.1.1 Entelos Company Information
- 6.1.2 Entelos Business Overview
- 6.1.3 Entelos Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Entelos Computer-assisted Drug Design Platform Product Portfolio
- 6.1.5 Entelos Recent Developments
- 6.2 Crown Bioscience
- 6.2.1 Crown Bioscience Company Information
- 6.2.2 Crown Bioscience Business Overview
- 6.2.3 Crown Bioscience Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Crown Bioscience Computer-assisted Drug Design Platform Product Portfolio
- 6.2.5 Crown Bioscience Recent Developments
- 6.3 Chemical Computing Group
- 6.3.1 Chemical Computing Group Company Information
- 6.3.2 Chemical Computing Group Business Overview
- 6.3.3 Chemical Computing Group Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Chemical Computing Group Computer-assisted Drug Design Platform Product Portfolio
- 6.3.5 Chemical Computing Group Recent Developments
- 6.4 Nimbus Therapeutics
- 6.4.1 Nimbus Therapeutics Company Information
- 6.4.2 Nimbus Therapeutics Business Overview
- 6.4.3 Nimbus Therapeutics Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Nimbus Therapeutics Computer-assisted Drug Design Platform Product Portfolio
- 6.4.5 Nimbus Therapeutics Recent Developments
- 6.5 Schrodinger
- 6.5.1 Schrodinger Company Information
- 6.5.2 Schrodinger Business Overview
- 6.5.3 Schrodinger Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Schrodinger Computer-assisted Drug Design Platform Product Portfolio
- 6.5.5 Schrodinger Recent Developments
- 6.6 Dassault Systemes
- 6.6.1 Dassault Systemes Company Information
- 6.6.2 Dassault Systemes Business Overview
- 6.6.3 Dassault Systemes Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Dassault Systemes Computer-assisted Drug Design Platform Product Portfolio
- 6.6.5 Dassault Systemes Recent Developments
- 6.7 Genedata
- 6.7.1 Genedata Company Information
- 6.7.2 Genedata Business Overview
- 6.7.3 Genedata Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Genedata Computer-assisted Drug Design Platform Product Portfolio
- 6.7.5 Genedata Recent Developments
- 6.8 Biognos
- 6.8.1 Biognos Company Information
- 6.8.2 Biognos Business Overview
- 6.8.3 Biognos Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Biognos Computer-assisted Drug Design Platform Product Portfolio
- 6.8.5 Biognos Recent Developments
- 6.9 Leadscope
- 6.9.1 Leadscope Company Information
- 6.9.2 Leadscope Business Overview
- 6.9.3 Leadscope Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Leadscope Computer-assisted Drug Design Platform Product Portfolio
- 6.9.5 Leadscope Recent Developments
- 6.10 Rhenovia Pharma Limited
- 6.10.1 Rhenovia Pharma Limited Company Information
- 6.10.2 Rhenovia Pharma Limited Business Overview
- 6.10.3 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Rhenovia Pharma Limited Computer-assisted Drug Design Platform Product Portfolio
- 6.10.5 Rhenovia Pharma Limited Recent Developments
- 6.11 Compugen
- 6.11.1 Compugen Company Information
- 6.11.2 Compugen Business Overview
- 6.11.3 Compugen Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Compugen Computer-assisted Drug Design Platform Product Portfolio
- 6.11.5 Compugen Recent Developments
- 6.12 Certara LP
- 6.12.1 Certara LP Company Information
- 6.12.2 Certara LP Business Overview
- 6.12.3 Certara LP Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Certara LP Computer-assisted Drug Design Platform Product Portfolio
- 6.12.5 Certara LP Recent Developments
- 6.13 Prosarix
- 6.13.1 Prosarix Company Information
- 6.13.2 Prosarix Business Overview
- 6.13.3 Prosarix Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Prosarix Computer-assisted Drug Design Platform Product Portfolio
- 6.13.5 Prosarix Recent Developments
- 6.14 Simulations Plus
- 6.14.1 Simulations Plus Company Information
- 6.14.2 Simulations Plus Business Overview
- 6.14.3 Simulations Plus Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Simulations Plus Computer-assisted Drug Design Platform Product Portfolio
- 6.14.5 Simulations Plus Recent Developments
- 6.15 Strand Life Sciences
- 6.15.1 Strand Life Sciences Company Information
- 6.15.2 Strand Life Sciences Business Overview
- 6.15.3 Strand Life Sciences Computer-assisted Drug Design Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Strand Life Sciences Computer-assisted Drug Design Platform Product Portfolio
- 6.15.5 Strand Life Sciences Recent Developments
7 North America
- 7.1 North America Computer-assisted Drug Design Platform Market Size (2021-2032)
- 7.2 North America Computer-assisted Drug Design Platform Market Size by Type
- 7.2.1 North America Computer-assisted Drug Design Platform Market Size by Type (2021-2026)
- 7.2.2 North America Computer-assisted Drug Design Platform Market Size by Type (2027-2032)
- 7.2.3 North America Computer-assisted Drug Design Platform Market Share by Type (2021-2032)
- 7.3 North America Computer-assisted Drug Design Platform Market Size by Application
- 7.3.1 North America Computer-assisted Drug Design Platform Market Size by Application (2021-2026)
- 7.3.2 North America Computer-assisted Drug Design Platform Market Size by Application (2027-2032)
- 7.3.3 North America Computer-assisted Drug Design Platform Market Share by Application (2021-2032)
- 7.4 North America Computer-assisted Drug Design Platform Market Size by Country
- 7.4.1 North America Computer-assisted Drug Design Platform Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
- 7.4.3 North America Computer-assisted Drug Design Platform Market Size by Country (2027-2032)
- 7.4.4 North America Computer-assisted Drug Design Platform Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Computer-assisted Drug Design Platform Market Size (2021-2032)
- 8.2 Europe Computer-assisted Drug Design Platform Market Size by Type
- 8.2.1 Europe Computer-assisted Drug Design Platform Market Size by Type (2021-2026)
- 8.2.2 Europe Computer-assisted Drug Design Platform Market Size by Type (2027-2032)
- 8.2.3 Europe Computer-assisted Drug Design Platform Market Share by Type (2021-2032)
- 8.3 Europe Computer-assisted Drug Design Platform Market Size by Application
- 8.3.1 Europe Computer-assisted Drug Design Platform Market Size by Application (2021-2026)
- 8.3.2 Europe Computer-assisted Drug Design Platform Market Size by Application (2027-2032)
- 8.3.3 Europe Computer-assisted Drug Design Platform Market Share by Application (2021-2032)
- 8.4 Europe Computer-assisted Drug Design Platform Market Size by Country
- 8.4.1 Europe Computer-assisted Drug Design Platform Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
- 8.4.3 Europe Computer-assisted Drug Design Platform Market Size by Country (2027-2032)
- 8.4.4 Europe Computer-assisted Drug Design Platform Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Computer-assisted Drug Design Platform Market Size (2021-2032)
- 9.2 China Computer-assisted Drug Design Platform Market Size by Type
- 9.2.1 China Computer-assisted Drug Design Platform Market Size by Type (2021-2026)
- 9.2.2 China Computer-assisted Drug Design Platform Market Size by Type (2027-2032)
- 9.2.3 China Computer-assisted Drug Design Platform Market Share by Type (2021-2032)
- 9.3 China Computer-assisted Drug Design Platform Market Size by Application
- 9.3.1 China Computer-assisted Drug Design Platform Market Size by Application (2021-2026)
- 9.3.2 China Computer-assisted Drug Design Platform Market Size by Application (2027-2032)
- 9.3.3 China Computer-assisted Drug Design Platform Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Computer-assisted Drug Design Platform Market Size (2021-2032)
- 10.2 Asia Computer-assisted Drug Design Platform Market Size by Type
- 10.2.1 Asia Computer-assisted Drug Design Platform Market Size by Type (2021-2026)
- 10.2.2 Asia Computer-assisted Drug Design Platform Market Size by Type (2027-2032)
- 10.2.3 Asia Computer-assisted Drug Design Platform Market Share by Type (2021-2032)
- 10.3 Asia Computer-assisted Drug Design Platform Market Size by Application
- 10.3.1 Asia Computer-assisted Drug Design Platform Market Size by Application (2021-2026)
- 10.3.2 Asia Computer-assisted Drug Design Platform Market Size by Application (2027-2032)
- 10.3.3 Asia Computer-assisted Drug Design Platform Market Share by Application (2021-2032)
- 10.4 Asia Computer-assisted Drug Design Platform Market Size by Country
- 10.4.1 Asia Computer-assisted Drug Design Platform Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
- 10.4.3 Asia Computer-assisted Drug Design Platform Market Size by Country (2027-2032)
- 10.4.4 Asia Computer-assisted Drug Design Platform Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size by Type
- 11.2.1 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size by Application
- 11.3.1 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country
- 11.4.1 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Computer-assisted Drug Design Platform Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst